Statistically significant diurnal variations in plasma growth hormone (GH) were found to occur in handled male rats. Peak GH values (at midday) appeared to be inversely correlated with the diurnal peak of plasma corticosterone (CS) which occurred after the onset of darkness. Brain amines were examined in the following regions: cortex, striatum, septum, amygdala, pons, midbrain, and hypothalamus. Statistically significant diurnal cycles of serotonin (5-HT) concentration were found in the amygdala and midbrain, while an ultradian cycle of 5-HT was present in the striatum. Striatum and pons also showed significant diurnal alterations in norepinephrine (NE) levels. Ultradian dopamine (DA) cycles were significant in all regions examined. Plasma GH changes were found to be directly correlated with midbrain and amygdala 5-HT levels and with DA levels of all areas except the amygdala. Plasma CS was found to be inversely correlated with striatal and cortical DA and with 5-HT levels of amygdala.

Keywords:
Norepinephrine, Dopamine, Serotonin, Growth hormone, Corticosterone, Diurnal rhythms
This content is only available via PDF.
© 1975 S. Karger AG, Basel
1975
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.